Patents by Inventor Michael Wijaranakula

Michael Wijaranakula has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tolerogenic DNA vaccine
    Patent number: 11279745
    Abstract: The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: March 22, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Jay Chaplin, Michael Wijaranakula
  • Tolerogenic DNA Vaccine
    Publication number: 20200339650
    Abstract: The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
    Type: Application
    Filed: April 26, 2019
    Publication date: October 29, 2020
    Inventors: Jay Chaplin, Michael Wijaranakula
  • Tolerogenic DNA Vaccine
    Publication number: 20180117133
    Abstract: The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
    Type: Application
    Filed: November 1, 2017
    Publication date: May 3, 2018
    Inventors: Jay Chaplin, Michael Wijaranakula